Viewing nowCombinationTwinstar Tablet 40/5 mg
Telmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.

MFDS item code 201005081 · Approved 2010.08.19 · Insurance code 653501270
Treatment of essential hypertension not controlled with monotherapy
This medication is used for patients with essential hypertension whose blood pressure is not adequately controlled by monotherapy with either telmisartan or amlodipine. It helps effectively manage high blood pressure and protect heart and vascular health. Therefore, this treatment option is chosen to improve symptoms in cases where blood pressure control is difficult.
The recommended dose of this medicine is 1 tablet once daily, taken with water regardless of meals. If possible, it is recommended to take it at the same time every day (e.g., in the morning). Before administering this medicine, it is recommended that the doses of the individual components (telmisartan or amlodipine) be adjusted. However, if blood pressure is not controlled with the individual components as follows, switching directly to this medicine may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. - 80/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or this medicine 40/10 mg. Patients taking telmisartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience (limited to this medicine 40/5 mg and 80/10 mg). O Patients with renal impairment: No dose adjustment is necessary in patients with mild to moderate renal impairment. For patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. O Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. O Elderly patients: The usual amlodipine dosage is recommended for elderly patients, but caution should be exercised when increasing the dose (see section '3. Patients requiring careful administration'). For elderly patients 75 years of age or older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.
Use of this medicine is not recommended in pediatric patients 18 years of age or younger because its safety and efficacy have not been established.
This drug should not be taken by pregnant women or women who may become pregnant, especially in the second and third trimesters, as it can have serious effects on the fetus. Additionally, it should not be administered to patients who have an allergy to any of the main ingredients or similar drugs, severe liver dysfunction, hypotension, or serious heart-related diseases. It is also advisable for patients with cholestatic disease or nursing mothers to avoid this medication. Patients with specific heart diseases, liver dysfunction, gastrointestinal diseases, and those with impaired kidney function should use this drug cautiously and require regular medical supervision. This medication lowers blood pressure, which may result in hypotension, necessitating appropriate action if this occurs. Moreover, there is a risk of elevated potassium levels in the blood, so potassium levels should be monitored through blood tests. This medication may impact heart or kidney function, requiring special caution for patients with related diseases. Caution is needed when driving or operating machinery, as dizziness or drowsiness may occur. Interactions with other medications may occur while taking this drug, so it is essential to inform healthcare providers of any current medications. In cases of overdose, severe hypotension or cardiac dysfunction may manifest, requiring immediate medical attention. Finally, store this product out of reach of children, and it is safest to open the packaging just before taking the medication.
Not everyone experiences these, and they can vary from person to person.
This drug is sensitive to light and should be stored in a container that protects from light. Additionally, it should be stored at room temperature between 1 degree and 30 degrees Celsius to maintain its efficacy.
This is a biconvex oval dual tablet that is white and light blue.
30 tablets (10 tablets/PTP x 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
ILDONG Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Genewon Science Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.